Results 121 to 130 of about 46,693 (216)

Muscarinic agonists for schizophrenia: Bridging preclinical evidence and clinical enthusiasm

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 19, Page 5701-5731, October 2026.
Abstract Antipsychotic drugs targeting dopamine receptors have been used to treat schizophrenia for decades, primarily alleviating positive symptoms such as hallucinations and delusions. However, they provide limited benefit for cognitive and negative symptoms—major contributors to poor outcomes—and are frequently associated with significant side ...
Brian J. Morris, Judith A. Pratt
wiley   +1 more source

Neural Cell Models of Specific Reading Disabilities: Identification of Cellular and Transcriptome Alterations

open access: yesGenes, Brain and Behavior, Volume 25, Issue 5, October 2026.
Neural cell phenotypes were tested using cells derived from two pairs of siblings strongly discordant for reading—probands with severe RD and their strong‐reader siblings. We observed significant differences in outgrowth in the neurosphere assay using the neural precursor cells (NPCs) derived from the probands compared to cells from their strong‐reader
Cathy L. Barr   +12 more
wiley   +1 more source

Selective loss of primary cilia and neurotrophic signaling in G51D α-synuclein mice highlights a common pathway to Parkinson's disease. [PDF]

open access: yesProc Natl Acad Sci U S A
Lin YE   +9 more
europepmc   +1 more source

Lewy Bodies Are Not Associated With Neuronal or Synaptic Loss in Dementia With Lewy Bodies. [PDF]

open access: yesNeuropathol Appl Neurobiol
Hawksworth JI   +7 more
europepmc   +1 more source

Asparagine Synthetase Deficiency: Neuropathological Evidence of Disrupted Cortical Development. [PDF]

open access: yesJIMD Rep
Bobić M   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy